Tetralogy of Fallot

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3303OMIM:618780Q21.3
Who is this for?
Show terms as
14Active trials61Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart defect, characterized by four structural abnormalities of the heart: a ventricular septal defect (VSD, a hole between the lower chambers of the heart), overriding aorta (the aorta is positioned over the VSD rather than solely over the left ventricle), right ventricular outflow tract obstruction (RVOTO, narrowing at or near the pulmonary valve that restricts blood flow to the lungs), and right ventricular hypertrophy (thickening of the right ventricle's muscular wall as a consequence of the obstruction). These defects result in oxygen-poor blood being pumped to the body, leading to cyanosis — a bluish discoloration of the skin, lips, and nail beds. TOF is typically diagnosed in the neonatal period or early infancy, often presenting with cyanosis, heart murmurs, and episodes called "tet spells" (hypercyanotic spells), during which the infant becomes suddenly very blue, irritable, and may lose consciousness due to a rapid drop in blood oxygen levels. Feeding difficulties, poor weight gain, and exercise intolerance may also be observed. The severity of symptoms depends largely on the degree of right ventricular outflow tract obstruction; some patients with milder obstruction may initially appear "pink" and present later in infancy. TOF can occur as an isolated cardiac malformation or as part of broader genetic syndromes, including 22q11.2 deletion syndrome (DiGeorge syndrome), trisomy 21 (Down syndrome), and Alagille syndrome. Several genes have been implicated, including NKX2-5, JAG1, TBX1, GATA4, and FOXC2, among others. The condition is treated surgically, with complete intracardiac repair typically performed in the first year of life. This surgery involves closure of the VSD and relief of the right ventricular outflow tract obstruction. Prior to definitive repair, severely cyanotic neonates may require a palliative shunt procedure (such as a Blalock-Taussig shunt) or prostaglandin infusion to maintain blood flow to the lungs. With modern surgical techniques, long-term survival is excellent, though patients require lifelong cardiac follow-up for potential complications including pulmonary regurgitation, arrhythmias, right ventricular dysfunction, and the possible need for pulmonary valve replacement later in life.

Clinical phenotype terms— hover any for plain English:

Abnormal nasal morphologyHP:0005105Underdeveloped supraorbital ridgesHP:0009891
Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

10 events
Jan 2026Effect of Exercises on Ventilatory Function in Adult With TOF

Cairo University — NA

TrialNOT YET RECRUITING
Nov 2025Role of CT in Tetralogy of Fallot Diagnosis

Assiut University

TrialNOT YET RECRUITING
Sep 2025Assessment of Microvascular Circulation in the Pediatric Cardiac Surgery Patient

Boston Children's Hospital

TrialNOT YET RECRUITING
Jun 2025Quality of Life in Operated Adult Patients With Tetralogy of Fallot and Correlation With Myocardial Strain Analysis by CMR

Assiut University

TrialNOT YET RECRUITING
May 2025Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial

The University of Hong Kong — PHASE4

TrialRECRUITING
Mar 2025Investigation of Tetralogy of Fallot in Neonates

Beijing Anzhen Hospital — NA

TrialRECRUITING
Apr 2024Role of 3D Echocardiography Knowledge-based Reconstruction in ACHD

Guy's and St Thomas' NHS Foundation Trust

TrialACTIVE NOT RECRUITING
Oct 2023Repaired Tetralogy of Fallot: Risc Score From MRI & Clinical Data to Predict the Need for Change of Treatment

University Medical Center Goettingen — NA

TrialNOT YET RECRUITING
Dec 2022Beta-blocker Administration for Cardiomyocyte Division

Weill Medical College of Cornell University — PHASE1

TrialRECRUITING
May 2022ALTERRA Post-Approval Study

Edwards Lifesciences

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Tetralogy of Fallot.

14 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

14 recruitingView all trials with filters →
Phase 41 trial
Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial
Phase 4
Actively Recruiting
PI: Chun-Ka Dr Wong, Clinical Assistant Professor (The University of Hong Kong/ Department of Medicin) · Sites: Hong Kong · Age: 1899 yrs
Phase 11 trial
Beta-blocker Administration for Cardiomyocyte Division
Phase 1
Actively Recruiting
PI: Bernhard Kuhn, MD (Weill Medical College of Cornell University) · Sites: New York, New York; Philadelphia, Pennsylvania +1 more
N/A6 trials
ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent
N/A
Active
PI: Evan Zahn, MD, FACC, FSCAI (Cedars-Sinai Heart Institute) · Sites: Los Angeles, California; Los Angeles, California +12 more
Evaluation of the GORE PV1 Device in Patients With Pulmonary Valve Dysfunction
N/A
Active
PI: Pedro del Nido, MD (Boston Children's Hospital) · Sites: Chicago, Illinois; Boston, Massachusetts +1 more · Age: 599 yrs
Quantifying New Heart Muscle Cells
N/A
Actively Recruiting
PI: Bernhard Kuhn, MD (Weill Medical College of Cornell University) · Sites: New York, New York · Age: 01 yrs
Early Versus Later Re-valving in Tetralogy of Fallot With Free Pulmonary Regurgitation
N/A
Actively Recruiting
PI: Lars Søndergaard, MD, DMSc (Rigshospitalet, Denmark) · Sites: Aarhus; Copenhagen +1 more · Age: 1299 yrs
Investigation of Tetralogy of Fallot in Neonates
N/A
Actively Recruiting
· Sites: Beijing, Beijing Municipality
PULSTA Transcatheter Pulmonary Valve Pre-Approval Study
N/A
Active
PI: Mario Carminati, PhD. MD. (Policlinico San Donato) · Sites: München, München; Milan, San Donato Milanese +9 more · Age: 1099 yrs
Other6 trials
ALTERRA Post-Approval Study
Active
· Sites: Birmingham, Alabama; Little Rock, Arkansas +22 more
Repaired Tetralogy of Fallot Italian Registry
Actively Recruiting
· Sites: Ancona, The Marches · Age: 1099 yrs
Molecular and Cellular Characterization of Cardiac Tissue in Postnatal Development
Actively Recruiting
PI: Michael E Davis, PhD (Emory University) · Sites: Atlanta, Georgia · Age: 020 yrs
Role of 3D Echocardiography Knowledge-based Reconstruction in ACHD
Active
PI: Dario Luis Leal de Freitas, BSc (Guy's and St Thomas' NHS Foundation Trust) · Sites: London · Age: 1899 yrs
Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases
Actively Recruiting
PI: Alexander Egbe, MBBS, MPH (Mayo Clinic) · Sites: Rochester, Minnesota · Age: 1899 yrs
French National Registry of Patients With Tetralogy of Fallot and Implantable Cardioverter Defibrillator
Actively Recruiting
PI: Victor Waldmann, MD (Paris Sudden Death Expertise Center) · Sites: Paris · Age: 1899 yrs

Specialists

Showing 25 of 61View all specialists →
LM
Lee Benson, MD
Specialist
PI on 1 active trial1 Tetralogy of Fallot publication
JM
John P. Cheatham, MD
TULSA, OK
Specialist
PI on 1 active trial
LM
Lisa Bergersen, MD, MPH
BOSTON, MA
Specialist
PI on 1 active trial
PM
Petros V Anagnostopoulos, MD
MADISON, WI
Specialist
PI on 1 active trial
EF
Evan Zahn, MD, FACC, FSCAI
NEW HAVEN, CT
Specialist
PI on 1 active trial
FM
Felice Su, MD
PALO ALTO, CA
Specialist
PI on 1 active trial
GM
Glen Van Arsdell, MD
Specialist
PI on 1 active trial1 Tetralogy of Fallot publication
RP
Richard Whitlock, MD, PhD
AUGUSTA, GA
Specialist
PI on 1 active trial
MM
Michael Hofbeck, MD
Specialist
PI on 1 active trial
DM
Dian Kesumarini, MD
Specialist
PI on 1 active trial
AM
Alexander Egbe, MBBS, MPH
ROCHESTER, MN
Specialist
PI on 2 active trials
BM
Beatrice BONELLO, MD
Specialist
PI on 1 active trial
CM
Charles B Higgins, MD
Specialist
PI on 2 active trials
AM
Arpit Agarwal, MD
SAN ANTONIO, TX
Specialist
PI on 1 active trial1 Tetralogy of Fallot publication
AM
Aymen N Naguib, MD
COLUMBUS, OH
Specialist
PI on 1 active trial1 Tetralogy of Fallot publication
MM
Mark Fogel, MD
Philadelphia, Pennsylvania
Specialist

Rare Disease Specialist

PI on 3 active trials
AM
Alfio Bronco, MD
Specialist
PI on 1 active trial1 Tetralogy of Fallot publication
BM
Bernhard Kuhn, MD
NEW YORK CITY, NY
Specialist
PI on 2 active trials
JM
Jae Young Choi, PhD. MD.
Specialist
PI on 1 active trial
GM
Gregor Krings, PhD. MD.
CLEVELAND, OH
Specialist
PI on 1 active trial1 Tetralogy of Fallot publication
SM
Seong Ho Kim, PhD. MD.
Specialist
PI on 1 active trial
AM
Ahmet Çelebi, PhD. MD.
Specialist
PI on 1 active trial1 Tetralogy of Fallot publication
JM
Jose Luis Zunzunegui, PhD. MD.
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Tetralogy of Fallot.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Tetralogy of FallotForum →

No community posts yet. Be the first to share your experience with Tetralogy of Fallot.

Start the conversation →

Latest news about Tetralogy of Fallot

Disease timeline:

New recruiting trial: Repaired Tetralogy of Fallot Italian Registry

A new clinical trial is recruiting patients for Tetralogy of Fallot

New recruiting trial: Molecular and Cellular Characterization of Cardiac Tissue in Postnatal Development

A new clinical trial is recruiting patients for Tetralogy of Fallot

New recruiting trial: Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial

A new clinical trial is recruiting patients for Tetralogy of Fallot

New recruiting trial: French National Registry of Patients With Tetralogy of Fallot and Implantable Cardioverter Defibrillator

A new clinical trial is recruiting patients for Tetralogy of Fallot

New recruiting trial: Early Versus Later Re-valving in Tetralogy of Fallot With Free Pulmonary Regurgitation

A new clinical trial is recruiting patients for Tetralogy of Fallot

New recruiting trial: Quantifying New Heart Muscle Cells

A new clinical trial is recruiting patients for Tetralogy of Fallot

New recruiting trial: Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases

A new clinical trial is recruiting patients for Tetralogy of Fallot

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Tetralogy of Fallot

What is Tetralogy of Fallot?

Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart defect, characterized by four structural abnormalities of the heart: a ventricular septal defect (VSD, a hole between the lower chambers of the heart), overriding aorta (the aorta is positioned over the VSD rather than solely over the left ventricle), right ventricular outflow tract obstruction (RVOTO, narrowing at or near the pulmonary valve that restricts blood flow to the lungs), and right ventricular hypertrophy (thickening of the right ventricle's muscular wall as a consequence of the obstruction). These defects result

How is Tetralogy of Fallot inherited?

Tetralogy of Fallot follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Tetralogy of Fallot typically begin?

Typical onset of Tetralogy of Fallot is neonatal. Age of onset can vary across affected individuals.

Are there clinical trials for Tetralogy of Fallot?

Yes — 14 recruiting clinical trials are currently listed for Tetralogy of Fallot on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Tetralogy of Fallot?

25 specialists and care centers treating Tetralogy of Fallot are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.